AspenBio Pharma (APPY) Prices 6.1M Offering at $2/Share
Tweet Send to a Friend
Up)
AspenBio Pharma, Inc. (Nasdaq: APPY), has priced an underwritten public offering of 6,100,000 shares of common stock at an offering price of $2.00 per share. The number of shares and offering price reflect a one-for-six reverse stock split implemented by the company to be effective on June 20, 2012. The gross proceeds to AspenBio from this offering are expected to be $12.2 million, before deducting underwriting discounts and commissions and other estimated offering expenses. The offering is expected to close on June 25, 2012, subject to customary closing conditions. AspenBio has also granted the underwriters a 45-day option to purchase up to an additional 915,000 shares of common stock to cover over-allotments, if any. All of the shares in the offering are to be sold by AspenBio.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Baltic Trading (BALT) to Sell 5.58M Common at $3.60/Share
- PGT (PGTI) Secondary Offering Size Increased, Priced at $7.75/Share
- Ford Motor (F) Will Ramp Production, Halves Two-Week Plant Idling
Create E-mail Alert Related Categories
Corporate News, Equity Offerings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
